Management of Decubitus Ulcers in Admitted Patients
Surgical debridement of necrotic tissue combined with broad-spectrum antibiotics targeting polymicrobial organisms (Gram-positive, Gram-negative, and anaerobes) is the cornerstone of managing infected decubitus ulcers in hospitalized patients. 1
Immediate Assessment and Risk Stratification
Upon admission, evaluate the ulcer for:
- Depth of tissue involvement (superficial vs. deep tissue destruction extending to bone) 1
- Signs of infection: spreading cellulitis, purulent drainage, systemic signs (fever, tachycardia, hypotension, altered mental status) 1
- Location: most commonly ischium, sacrum, and greater trochanter 1
- Patient risk factors: frail elderly status, chronic comorbidities, immobility, malnutrition, poor circulation 2, 3
Surgical Intervention
Surgical debridement is necessary to remove necrotic tissue in all infected or deep pressure ulcers. 1 This is non-negotiable for achieving source control and preventing progression to systemic sepsis.
For extensive ulcers with bone involvement or large tissue defects:
- Consider musculocutaneous or fasciocutaneous flaps for definitive coverage 4
- These flaps are superior to cutaneous flaps alone for long-standing pressure sores 4
Antibiotic Therapy
Administer broad-spectrum antibiotics for severe pressure ulcer infections, including those with spreading cellulitis or systemic signs of infection. 1
The antibiotic regimen must cover:
- Gram-positive organisms: S. aureus, Enterococcus spp. 1
- Gram-negative organisms: Proteus mirabilis, E. coli, Pseudomonas spp. 1
- Anaerobes: Peptococcus spp., Bacteroides fragilis, Clostridium perfringens 1
MRSA Coverage Decision Algorithm
Add MRSA-directed antibiotics when: 1
- Local epidemiology shows >20% MRSA in invasive hospital isolates
- High community MRSA circulation
- Patient has specific MRSA risk factors (recent hospitalization, healthcare exposure, injection drug use)
- Severe systemic infection requiring ICU admission
Microbiological Sampling
Collect samples for bacterial AND fungal cultures from all surgical debridements before initiating antibiotics. 1 Adjust therapy based on culture results, as polymicrobial infections are the rule rather than the exception. 1
Pressure Relief and Wound Care
Encourage active movement and provide passive pressure relief through frequent position changes as the most beneficial prevention and treatment strategy. 3 This is more important than any topical therapy.
Specific measures include:
- Pressure-reducing surfaces and mattresses 3
- Repositioning every 2 hours for immobile patients 2
- Avoid prolonged pressure over bony prominences 5
- Address friction and shear forces 2
Addressing Underlying Risk Factors
Treat modifiable risk factors aggressively: 3
- Malnutrition: nutritional supplementation and consultation
- Poor circulation/hypoperfusion: optimize hemodynamics and treat underlying vascular disease
- Pain: adequate analgesia to facilitate movement
- Underlying diseases impairing mobility: physical therapy, treatment of neurological conditions
Vascular Assessment
Perform vascular assessment if the ulcer is on a lower extremity, as up to 50% of leg ulcers have arterial involvement. 6 Measure ankle-brachial index (ABI) and pedal Doppler waveforms to detect peripheral artery disease, which significantly increases risk for non-healing and limb loss. 6
Critical Pitfalls to Avoid
- Do not rely on topical wound care alone without addressing infection through debridement and systemic antibiotics 1
- Do not delay surgical debridement in infected ulcers, as this leads to systemic sepsis and increased mortality 1
- Do not use narrow-spectrum antibiotics for infected pressure ulcers, as these infections are invariably polymicrobial 1
- Do not forget to assess and treat underlying systemic factors (nutrition, circulation, mobility) that perpetuate ulcer formation 3
- Do not assume all decubitus ulcers are preventable or curable, as poor circulation and cognitive impairment can make prophylaxis difficult 3
Documentation and Reassessment
Repeatedly reassess and document: 3
- Feasibility and implementation of pressure-relief measures
- Efficacy of current treatment strategy
- Changes in ulcer characteristics (size, depth, infection signs)
- Patient's overall clinical trajectory and comorbidity management